Mutation analysis of the MSMB gene in familial prostate cancer

被引：0
|
作者：
Z Kote-Jarai
D Leongamornlert
M Tymrakiewicz
H Field
M Guy
A A Al Olama
J Morrison
L O'Brien
R Wilkinson
A Hall
E Sawyer
K Muir
F Hamdy
J Donovan
D Neal
D Easton
R Eeles
机构：
[1] Translational Cancer Genetics Team,Department of Oncology. University of Cambridge
[2] The Institute of Cancer Research,Nuffield Department of Surgery
[3] Strangeways Laboratory,Department of Social Medicine
[4] CR-UK Genetic Epidemiology Unit,Departments of Oncology and Surgery
[5] University of Cambridge,undefined
[6] Strangeways Laboratory,undefined
[7] University of Nottingham Medical School,undefined
[8] Queens Medical Centre,undefined
[9] University of Oxford,undefined
[10] University of Bristol,undefined
[11] Surgical Oncology (Uro-Oncology: S4),undefined
[12] University of Cambridge,undefined
[13] Box 279,undefined
[14] Addenbrooke's Hospital,undefined
[15] Cancer Research UK Cambridge Research Institute & Li Ka Shing Centre,undefined
[16] The Royal Marsden NHS Foundation Trust,undefined
来源：
British Journal of Cancer | 2010年 / 102卷
关键词：
prostate cancer; SNP; gene expression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：414 / 418
页数：4
相关论文
共 50 条
  • [31] Weighted Gene Coexpression Network Analysis of Prostate Cancer
    Ma, Yinjiao
    Zhang, Lingling
    Geneus, Christian
    Gong, Haijun
    2015 IEEE 5TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL ADVANCES IN BIO AND MEDICAL SCIENCES (ICCABS), 2015,
  • [32] Molecular analysis of the FHIT gene in human prostate cancer
    Alain Latil
    Ivan Bièche
    Georges Fournier
    Olivier Cussenot
    Sandrine Pesche
    Rosette Lidereau
    Oncogene, 1998, 16 : 1863 - 1868
  • [33] Whole-genome gene expression analysis in urine samples of patients with prostate cancer and benign prostate hyperplasia
    Ozdemir, Taha Resid
    Simsir, Adnan
    Onay, Huseyin
    Cureklibatir, Ibrahim
    Ozkinay, Ferda
    Akin, Haluk
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (10) : 607.e15 - 607.e24
  • [34] Somatic mutation analysis of MYH11in breast and prostate cancer
    Pia Alhopuro
    Auli Karhu
    Robert Winqvist
    Kati Waltering
    Tapio Visakorpi
    Lauri A Aaltonen
    BMC Cancer, 8
  • [35] Key pathways in prostate cancer with SPOP mutation identified by bioinformatic analysis
    Ding, Guanxiong
    Sun, Jianliang
    Jiang, Lianhua
    Gao, Peng
    Zhou, Qidong
    Wang, Jianqing
    Tong, Shijun
    OPEN MEDICINE, 2020, 15 (01): : 1039 - 1047
  • [36] Molecular analysis of the FHIT gene in human prostate cancer
    Latil, A
    Bièche, I
    Fournier, G
    Cussenot, O
    Pesche, S
    Lidereau, R
    ONCOGENE, 1998, 16 (14) : 1863 - 1868
  • [37] BRCA2 gene mutation and prostate cancer risk Comprehensive review and update
    Junejo, Noor N.
    AlKhateeb, Sultan S.
    SAUDI MEDICAL JOURNAL, 2020, 41 (01) : 9 - 17
  • [38] Point mutation of the p53 gene is an infrequent event in untreated prostate cancer
    Kunimi, K
    Amano, T
    Uchibayashi, T
    CANCER DETECTION AND PREVENTION, 1996, 20 (03): : 218 - 222
  • [39] Gene expression analysis of prostate cancers
    Luo, JH
    Yu, YP
    Cieply, K
    Lin, F
    Deflavia, P
    Dhir, R
    Finkelstein, S
    Michalopoulos, G
    Becich, M
    MOLECULAR CARCINOGENESIS, 2002, 33 (01) : 25 - 35
  • [40] Age limit for familial prostate cancer screening
    Khatami, Fatemeh
    Afsari, Rouhollah
    Khajavi, Alireza
    Aghamir, Seyed Mohammad Kazem
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2025, 16 (01) : 187 - 191
12345